Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia

Gemtuzumab ozogamicin (GO) is a recombinant humanized immunoglobulin G4 anti-cluster of differentiation (CD)33 monoclonal antibody conjugated to N-acetyl-γ calicheamicin dimethylhydrazide, a naturally potent antibiotic. It has been introduced for the treatment of acute promyelocytic leukemia (APL),...

Descripción completa

Detalles Bibliográficos
Autores principales: AZUMA, YOSHIKO, NAKAYA, AYA, HOTTA, MASAAKI, FUJITA, SHINYA, TSUBOKURA, YUKIE, YOSHIMURA, HIDEAKI, SATAKE, ATSUSHI, ISHII, KAZUYOSHI, ITO, TOMOKI, NOMURA, SHOSAKU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906953/
https://www.ncbi.nlm.nih.gov/pubmed/27330760
http://dx.doi.org/10.3892/mco.2016.864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906953/
https://www.ncbi.nlm.nih.gov/pubmed/27330760
http://dx.doi.org/10.3892/mco.2016.864

Ejemplares similares